Everything below concerns AOD-9604. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Slavery was widespread in Africa, which pursued both internal and external slave trade. In the Senegambia region, between 1300 and 1900, close to one-third of the population was enslaved. In early Islamic states of the western Sahel, including Ghana, Mali, Segou, and Songhai, about a third of the population were enslaved. In European courtly society, and European aristocracy, black African slaves and their children became visible in the late 1300s and 1400s. Starting with Frederick II, Holy Roman Emperor, black Africans were included in the retinue. In 1402 an Ethiopian embassy reached Venice. In the 1470s black Africans were painted as court attendants in wall paintings that were displayed in Mantua and Ferrara. In the 1490s black Africans were included on the emblem of the Duke of Milan. During the trans-Saharan slave trade, slaves from West Africa were transported across the Sahara desert to North Africa to be sold to Mediterranean and Middle eastern civilizations. During the Red Sea slave trade, slaves were transported from Africa across the Red Sea to the Arabian Peninsula. The Indian Ocean slave trade, sometimes known as the east African slave trade, was multi-directional. Africans were sent as slaves to the Arabian Peninsula, to Indian Ocean islands (including Madagascar), to the Indian subcontinent, and later to the Americas. These traders captured Bantu peoples (Zanj) from the interior in present-day Kenya, Mozambique and Tanzania and brought them to the coast. There, the slaves gradually assimilated in rural areas, particularly on Unguja and Pemba islands.
The order offered sickness and death insurance, assuring its members would be buried by Jewish law and become good American citizens. Order of United Hebrew Brothers - Founded in 1915. in 1917 was reported to have 1,800 members and 12 lodges in New York City. Orders stated objectives included promoting social intercourse, discussions of subjects relating to their community, and acting upon them. Provided free burials, helped members in distress, and encouraged enrollment in the Postal Life Insurance Company. United Order of True Sisters - Founded by Henrietta Bruckman, wife of a prominent New York doctor, with 12 other ladies to assist Hebrew housewives. Had 5,991 members in 21 lodges in 1918. Had 12,000 members in 1995. Headquarters in New York. National structure called "Grand Lodge". Has degrees, secret ritual regalia, etc. Originally German-speaking, the first English lodge was organized in 1892, by 1918 German language was "essentially discontinued in all lodges". Although originally a benevolent society for sick and widows, by the late 1970s, had become primarily a philanthropic group, particularly with cancer-related causes. The United Order True Sister Inc, Cancer Service created in 1947, contributes $300,000 a year to cancer patients and specialized care hospitals in 13 and Israel. Workmen's Circle
The surgeon cuts the cartilage portion of the hump with a scalpel, and chisels the bone portion with an osteotome (bone chisel). After chiselling away the main mass of the nasal hump with an osteotome, the surgeon then sculpts, refines, and smoothens the cut nasal bones with rasps (files).
Sources: en.wikipedia.org
If increased glucagon does not raise blood sugar levels to normal, the adrenal glands release epinephrine. Epinephrine works to also increase gluconeogenesis and glycogenolysis, while also decreasing the use of glucose by organs, protecting the brain's glucose supply. After hypoglycemia has been prolonged, cortisol and growth hormone are released to continue gluconeogenesis and glycogenolysis, while also preventing the use of glucose by other organs. The effects of cortisol and growth hormone are far less effective than epinephrine. In a state of hypoglycemia, the brain also signals a sense of hunger and drives the person to eat, in an attempt to increase glucose.
=== Female pubertal development === Estrogens are responsible for the development of female secondary sexual characteristics during puberty, including breast development, widening of the hips, and female fat distribution. Conversely, androgens are responsible for pubic and body hair growth, as well as acne and axillary odor.
== Medical uses == Diclofenac is used to treat pain related to arthritis, dysmenorrhea, rheumatic diseases and other inflammatory disorders, kidney stones and gallstones. An additional indication is the treatment of acute migraines. Diclofenac is used to treat mild to moderate postoperative or post-traumatic pain, in particular when inflammation is also present. Diclofenac ophthalmic is indicated for the treatment of postoperative inflammation in people who have undergone cataract extraction and for the temporary relief of pain and photophobia in people undergoing corneal refractive surgery. Diclofenac may also help with actinic keratosis and with acute pain caused by minor strains, sprains and contusions. In many countries, eye drops are sold to treat acute and chronic nonbacterial inflammation of the anterior part of the eyes (such as postoperative states). The eye drops have also been used to manage pain for traumatic corneal abrasion. Diclofenac is often used to treat chronic pain associated with cancer, especially if inflammation is present.
Music hall historian Harold Scott wrote that: "..he sang at his piano perched upon a music stool always on the point of collapse, made jokes, gave satirical opinions upon the events of the day and commented unsparingly upon his own prodigious girth; the whole in the breathless manner and rather asthmatical voice, the management of which was the secret of his style." He made several recordings for Odeon Records, including "Limerickitis", and "Suffragettes' Anthem" (not to be confused with "The March of the Women"), in 1910, in which he was "careful to navigate that narrow line between being offensive and being uncontroversial." On the record, he introduces the song by saying that "the remarks [in the song] do not apply to those earnest ladies who are really earnest in their works, but rather the mountebank militants whose extraordinary antics seem to be alienating the sympathies of most right minded people, I refer to the Suffragettes...". The song itself is a parody of Gilbert and Sullivan's "Three Little Maids Are We" and Vesta Victoria's hit "Waiting at the Church": "There was I waiting in the cold, waiting in the cold, chained up in the cold...". In July 1912, Gammon was considered sufficiently respectable to be the opening act (other than a pair of acrobats, Pipifax and Panlo) at the first ever Royal Command Performance for music hall artists, held at the Palace Theatre in front of King George V, Queen Mary and Edward, Prince of Wales. He was a Freemason.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.